Monday, July 2, 2012

GSK Will Pay $3-billion for Avandia, Paxil, Wellbutrin Violations


GlaxoSmithKline agreed to plead guilty and pay a record $3 billion in a deal with federal prosecutors over its marketing of Paxil and Wellburtrin, and for failing to report safety problems with Avandia.



No comments: